3544 results for «2114»
3544 results
From theory to practice: the versatility of drug-coated balloons around the world
20 May 2025 – From EuroPCR 2025
Step into the world of drug-coated balloons (DCBs) with this EuroPCR 2025 session, tracing their journey from pioneering use in Europe to versatile applications worldwide. Discover the latest evidence on the safety and efficacy of both paclitaxel- and sirolimus-coated balloons across diverse lesion types—from straightforward to...
Full physiology: why and how to assess beyond coronary epicardial disease
20 May 2025 – From EuroPCR 2025
Understanding full coronary physiology is key to improving patient care. This EuroPCR 2025 session unpacks the concept and shows how to apply it easily in everyday clinical settings. Explore the latest ESC guidelines for managing patients with angina and no obstructive coronary artery disease (ANOCA), supported...
PCR's Got Talent Round 1 - Session 1
20 May 2025 – From EuroPCR 2025
Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.
Future-proof your TAVI programme: increased need to enhance pathway efficiencies
21 May 2025 – From EuroPCR 2025
Explore evolving guidelines, demographic changes, and new data shaping lifetime TAVI management. Learn precision strategies to optimise patient outcomes before, during, and after TAVI, including post-procedural care and PCI with the Evolut FX+ valve. Discover practical approaches to boost hospital efficiency and embrace innovative technologies that...
How do I confidently expand my drug-coated balloon practice?
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...
Tailoring transcatheter mitral therapies: a new era
20 May 2025 – From EuroPCR 2025
This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.
How to handle the most clinically relevant challenges in TAVI
21 May 2025 – From EuroPCR 2025
This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...
How to optimise TAVI outcomes in the Asian-Pacific population?
22 May 2025 – From EuroPCR 2025
What are the key considerations for TAVI in Asian-Pacific patients? This EuroPCR 2025 session focuses on optimising outcomes in anatomically and clinically specific contexts, such as patients with small annuli. Learn how the latest intra-annular self-expanding devices can help reduce post-procedural pacemaker implantation (PPI) rates, and...
Managing complex STEMI patients in diverse healthcare systems - Adapting best practices to local realities
20 May 2025 – From EuroPCR 2025
Addressing the complexities of STEMI management across diverse healthcare systems, this session highlights challenges and adaptive strategies tailored to geographic and resource-specific realities. Learn from regional experts on thrombus burden, late presentations, cardiogenic shock, and multivessel disease management.
If I can’t stent it, should I care? Unmasking hidden atherosclerosis through novel imaging techniques
22 May 2025 – From EuroPCR 2025
Unveil the potential of novel imaging techniques in identifying hidden atherosclerosis and silent inflammation. This session discusses the role of perivascular adipose tissue in plaque development, highlights advances in early inflammation detection, and explores clinical management of patients with athero-inflammation beyond traditional stenting options.
Innovations in TMVR and Intrepid trial updates
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...
Personalised Vascular Care Award - Competition
20 May 2025 – From EuroPCR 2025
Celebrate innovation in personalised vascular care through this award competition session. Presentations cover topics including coronary revascularisation decision-making, INOCA prevalence, endothelial shear stress, bifurcation stenting predictors, CT plaque analysis, and early STEMI discharge protocols.
Innovative approaches to thrombus removal: redefining acute thromboembolic management in ACS
21 May 2025 – From EuroPCR 2025
Unlock cutting-edge strategies for thrombus removal in acute coronary syndrome (ACS) with this EuroPCR 2025 session. Understand the mechanisms behind microvascular obstruction and no-reflow phenomena, and why effective thrombus management is crucial. Review the latest clinical evidence, from the Cheetah study to the ongoing TACTIC randomised...
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
Mitral TEER in challenging scenarios - Part 2
21 May 2025 – From EuroPCR 2025
This session focuses on challenging scenarios encountered during mitral transcatheter edge-to-edge repair (TEER). Learn about management of complications such as haemolysis, device malfunctions, and complex vascular access issues, supported by instructive case presentations including bailout strategies in cardiogenic shock and infective endocarditis.
Imaging-based strategies for complication management in STEMI
21 May 2025 – From EuroPCR 2025
Discover imaging-based strategies to manage complications during STEMI interventions. This session discusses diagnostic clues such as spasm, stuck devices, and slow flow, and illustrates complex scenarios including extreme stent challenges and application of CTO techniques to STEMI cases for optimized outcomes.
Management of non-culprit lesions in patients with ACS and multivessel disease
21 May 2025 – From EuroPCR 2025
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...
Complication management during mitral TEER procedures
21 May 2025 – From EuroPCR 2025
Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.
CTO, modern challenges and solutions
21 May 2025 – From EuroPCR 2025
Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.
TAVI for aortic regurgitation: on-label and off-label use
21 May 2025 – From EuroPCR 2025
This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.
